Great Novel Therapeutics Biotech & Medicals Corp Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Great Novel Therapeutics Biotech & Medicals Corp

Watchlist Manager

Watchlist

Price: 60.1 TWD -1.8% Market Closed

Market Cap: NT$3.2B

G	Great Novel Therapeutics Biotech & Medicals Corp TPEX:7427	TW
A	Arabian Contracting Services Company SJSC SAU:4071	SA
	Amco India Ltd BSE:530133	IN
M	Mercuries & Associates Holding Ltd TWSE:2905	TW
B	Belysse Group NV SWB:BDB	BE
V	Visteon Corp F:VS51	US
	Neuca SA F:7HD	PL
U	Univec Inc OTC:UNVC	US
	Chateau International Development Co Ltd TWSE:2722	TW

Profitability Summary

Great Novel Therapeutics Biotech & Medicals Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

19%

Sustainable 3Y Average Gross Margin

33%

Declining Gross Margin

100% > 19%

Negative Operating Margin

-1 901%

Negative 3Y Average Operating Margin

-6 417%

Declining Operating Margin

-1 344% > -1 901%

Negative Net Margin

-1 799%

Negative 3Y Average Net Margin

-6 086%

Declining Net Margin

-1 285% > -1 799%

Negative Free Cash Flow Margin

-1 480%

Negative 3Y Average Free Cash Flow Margin

-5 796%

Free Cash Flow Margin is Increasing

-1 775% > -1 480%

Negative ROE

-20%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-106%

Declining ROIC

-44% > -137%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.